Fagron is excited to share our continued partnership with Premier and the renewal of our GPO contract. This agreement covers Fagron’s entire high-quality portfolio, ready to administer compounded sterile preparations with application in acute and non-acute facilities.
"We are proud to continue our partnership with Premier and their member organizations, bringing critical and highly utilized medications with unique presentations and containers to help improve patient care.”
- MJ DeMott, Sr Director of National Accounts
For 20 years, FSS has been trusted by thousands of patient-focused healthcare facilities to deliver a reliable supply of high-quality sterile medications – produced through state-of-the-art cGMP compliant operations. FSS' DEA & FDA registered and inspected 503B outsourcing solutions support millions of patients across North America each year.
-
Fagron North America is a group of innovative, pharmaceutical facilities that focus on optimizing and innovating pharmaceutical compounding. Fagron North America is fully integrated with facilities specializing in 503A Compounding, 503B Human Drug Outsourcing, and providing pharmacists with raw ingredients, supplies, education, and technical support.
This post is related to:
Manufacturing: 503B Outsourcing Facilities, Compounding Services Distribution: GPOs, Buying Groups, COOPs
